Viewing Study NCT04739761


Ignite Creation Date: 2025-12-24 @ 12:44 PM
Ignite Modification Date: 2026-01-03 @ 5:54 PM
Study NCT ID: NCT04739761
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-10
First Post: 2021-01-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Trastuzumab deruxtecan View
None Human epidermal growth factor receptor 2 Positive Breast Cancer View
None Brain Metastasis View